Yu Yu

906 total citations
24 papers, 685 citations indexed

About

Yu Yu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yu Yu has authored 24 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Yu Yu's work include Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (7 papers). Yu Yu is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (7 papers). Yu Yu collaborates with scholars based in United States, China and Germany. Yu Yu's co-authors include Claudio Anasetti, Xue‐Zhong Yu, Kenrick Semple, Dapeng Wang, Kane Kaosaard, Chen Liu, Katayoun Aghajani, Fotini Gounari, Shilpa Keerthivasan and Honglin Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Yu Yu

24 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Yu United States 15 450 163 149 118 53 24 685
Gisela Cáceres United States 15 350 0.8× 360 2.2× 195 1.3× 118 1.0× 93 1.8× 27 787
Thorsten Gantke Germany 10 315 0.7× 211 1.3× 70 0.5× 223 1.9× 115 2.2× 15 661
Masamichi Isobe Japan 16 342 0.8× 141 0.9× 256 1.7× 97 0.8× 52 1.0× 66 728
Yaomei Wang China 12 234 0.5× 316 1.9× 116 0.8× 80 0.7× 58 1.1× 26 696
Ken-ichi Hirano Japan 10 284 0.6× 254 1.6× 48 0.3× 93 0.8× 30 0.6× 22 639
Hisako Kawata Japan 17 364 0.8× 209 1.3× 49 0.3× 72 0.6× 28 0.5× 25 676
Laurence Goffin Switzerland 15 330 0.7× 261 1.6× 51 0.3× 96 0.8× 31 0.6× 26 723
Deborah Ferriola United States 13 300 0.7× 242 1.5× 108 0.7× 57 0.5× 42 0.8× 32 707
Chaya Moroz Israel 18 285 0.6× 291 1.8× 104 0.7× 115 1.0× 73 1.4× 45 728
W Chen United States 8 424 0.9× 151 0.9× 99 0.7× 223 1.9× 10 0.2× 9 631

Countries citing papers authored by Yu Yu

Since Specialization
Citations

This map shows the geographic impact of Yu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Yu more than expected).

Fields of papers citing papers by Yu Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Yu. The network helps show where Yu Yu may publish in the future.

Co-authorship network of co-authors of Yu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Yu. A scholar is included among the top collaborators of Yu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Yu. Yu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Yu, et al.. (2023). Oxidative stress in the tumor microenvironment in gastric cancer and its potential role in immunotherapy. FEBS Open Bio. 13(7). 1238–1252. 7 indexed citations
2.
Wu, Yingjie, et al.. (2023). Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials. Journal of the Egyptian National Cancer Institute. 35(1). 32–32. 3 indexed citations
3.
Zhou, Zheng, Wenjing Yang, Tianming Yu, et al.. (2023). GPR120 promotes neutrophil control of intestinal bacterial infection. Gut Microbes. 15(1). 2190311–2190311. 10 indexed citations
4.
Wang, Yaqing, Jiaqi Liang, Shaowei Gao, et al.. (2022). Association of glioma CD44 expression with glial dynamics in the tumour microenvironment and patient prognosis. Computational and Structural Biotechnology Journal. 20. 5203–5217. 16 indexed citations
5.
Yu, Yu, Wenjing Yang, Tianming Yu, et al.. (2022). Glucose promotes regulatory T cell differentiation to maintain intestinal homeostasis. iScience. 25(9). 105004–105004. 11 indexed citations
6.
Yu, Xiuchong, et al.. (2020). Clinical significance of the molecular heterogeneity of gastrointestinal stromal tumors and related research: A systematic review. Oncology Reports. 43(3). 751–764. 10 indexed citations
7.
Yu, Yanbo, Wenjing Yang, Anthony J. Bilotta, et al.. (2020). STING controls intestinal homeostasis through promoting antimicrobial peptide expression in epithelial cells. The FASEB Journal. 34(11). 15417–15430. 26 indexed citations
8.
Chen, Jiao, Yaping Fan, Bomiao Cui, et al.. (2018). HMGN2: An Antitumor Effector Molecule of γδT Cells. Journal of Immunotherapy. 41(3). 118–124. 6 indexed citations
9.
Li, Junru, Huifang Li, Yu Yu, et al.. (2018). Mannan-binding lectin suppresses growth of hepatocellular carcinoma by regulating hepatic stellate cell activation via the ERK/COX-2/PGE2 pathway. OncoImmunology. 8(2). e1527650–e1527650. 25 indexed citations
10.
Zhou, Jia, Junru Li, Yu Yu, et al.. (2018). Mannan-binding lectin deficiency exacerbates sterile liver injury in mice through enhancing hepatic neutrophil recruitment. Journal of Leukocyte Biology. 105(1). 177–186. 13 indexed citations
11.
Wang, Dapeng, Yu Yu, Kelley M.K. Haarberg, et al.. (2013). Dynamic Change and Impact of Myeloid-Derived Suppressor Cells in Allogeneic Bone Marrow Transplantation in Mice. Biology of Blood and Marrow Transplantation. 19(5). 692–702. 58 indexed citations
12.
Kadlubar, Susan, Xifeng Wu, Lin, et al.. (2013). GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer. Pharmacogenomics and Personalized Medicine. 6. 9–9. 6 indexed citations
13.
Yu, Yu, Dapeng Wang, Kane Kaosaard, et al.. (2013). cRel is an essential transcription factor for the development of acute graft‐versus‐host disease in mice. European Journal of Immunology. 43(9). 2327–2337. 15 indexed citations
14.
Aghajani, Katayoun, Shilpa Keerthivasan, Yu Yu, & Fotini Gounari. (2012). Generation of CD4CreERT2 transgenic mice to study development of peripheral CD4‐T‐cells. genesis. 50(12). 908–913. 56 indexed citations
15.
Semple, Kenrick, Yu Yu, Dapeng Wang, Claudio Anasetti, & Xue‐Zhong Yu. (2011). Efficient and Selective Prevention of GVHD by Antigen-Specific Induced Tregs via Linked-Suppression in Mice. Biology of Blood and Marrow Transplantation. 17(3). 309–318. 41 indexed citations
16.
Yu, Yu, et al.. (2011). Sulfation of fulvestrant by human liver cytosols and recombinant SULT1A1 and SULT1E1. SHILAP Revista de lepidopterología. 4. 137–137. 17 indexed citations
17.
Semple, Kenrick, et al.. (2011). Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling. Blood. 117(11). 3096–3103. 67 indexed citations
18.
Yu, Yu, Dapeng Wang, Chen Liu, et al.. (2011). Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and RORγt in mice. Blood. 118(18). 5011–5020. 119 indexed citations
19.
Kovalovsky, Damián, Yu Yu, Marei Dose, et al.. (2009). β-Catenin/Tcf Determines the Outcome of Thymic Selection in Response to αβTCR Signaling. The Journal of Immunology. 183(6). 3873–3884. 25 indexed citations
20.
He, Yuxian, Angus Macdonald, Yu Yu, et al.. (2009). Recombinant Ov-ASP-1, a Th1-Biased Protein Adjuvant Derived from the Helminth Onchocerca volvulus, Can Directly Bind and Activate Antigen-Presenting Cells. The Journal of Immunology. 182(7). 4005–4016. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026